HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Richard Vile Selected Research
Richard Vile Research Topics
Disease
57
Neoplasms (Cancer)
11/2023 - 03/2002
16
Melanoma (Melanoma, Malignant)
01/2022 - 03/2002
12
Vesicular Stomatitis
11/2023 - 10/2002
6
Infections
12/2022 - 10/2012
5
Experimental Melanoma
06/2023 - 10/2014
3
Prostatic Neoplasms (Prostate Cancer)
03/2021 - 12/2007
3
Glioma (Gliomas)
06/2017 - 02/2015
2
Liver Neoplasms (Liver Cancer)
01/2023 - 01/2018
2
Virus Diseases (Viral Diseases)
01/2021 - 10/2012
2
Reoviridae Infections
03/2020 - 06/2011
2
Urinary Bladder Neoplasms (Bladder Cancer)
10/2019 - 06/2018
2
Non-Muscle Invasive Bladder Neoplasms
10/2019 - 06/2018
2
Brain Neoplasms (Brain Tumor)
06/2017 - 04/2016
1
Squamous Cell Carcinoma of Head and Neck
03/2020
1
Squamous Cell Neoplasms (Squamous Cell Cancer)
03/2020
1
Wounds and Injuries (Trauma)
11/2017
1
Diffuse Intrinsic Pontine Glioma
06/2017
1
Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
06/2017
1
Neuroblastoma
04/2016
1
Hypoxia (Hypoxemia)
04/2016
1
Carcinogenesis
01/2016
1
Sickle Cell Anemia (Hemoglobin S Disease)
01/2016
1
Colorectal Neoplasms (Colorectal Cancer)
05/2013
Drug/Important Bio-Agent (IBA)
21
Antigens
IBA
01/2022 - 03/2002
8
Neoplasm Antigens (Tumor Antigens)
IBA
11/2023 - 03/2002
7
Proteins (Proteins, Gene)
FDA Link
06/2018 - 11/2010
6
Neutralizing Antibodies
IBA
12/2022 - 01/2008
5
Cytokines
IBA
11/2017 - 05/2008
5
Vaccines
IBA
09/2008 - 10/2002
4
Immune Checkpoint Inhibitors
IBA
11/2023 - 03/2021
4
Antiviral Agents (Antivirals)
IBA
01/2021 - 11/2011
4
Complementary DNA (cDNA)
IBA
01/2016 - 11/2011
4
Cyclophosphamide (Cytoxan)
FDA Link
Generic
03/2015 - 01/2008
3
Interferons
IBA
11/2023 - 02/2011
3
Cancer Vaccines
IBA
12/2020 - 03/2002
3
Chemokines
IBA
01/2020 - 02/2011
3
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
11/2017 - 05/2010
3
Antibodies
IBA
05/2013 - 07/2007
3
Therapeutic Uses
IBA
10/2011 - 06/2003
3
Membrane Glycoproteins (Membrane Glycoprotein)
IBA
02/2006 - 10/2002
3
Glycoproteins (Glycoprotein)
IBA
02/2006 - 10/2002
2
Ligands
IBA
06/2023 - 03/2021
2
Interferon Type I
IBA
03/2021 - 01/2020
2
Chimeric Antigen Receptors
IBA
01/2020 - 06/2003
2
Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)
IBA
10/2019 - 06/2018
2
Mitomycin (Mitomycin-C)
FDA Link
Generic
10/2019 - 06/2018
2
PLX 4720
IBA
05/2015 - 05/2015
2
Conditioned Culture Media
IBA
02/2015 - 02/2011
2
Epitopes
IBA
11/2014 - 02/2006
2
Interleukins
IBA
03/2012 - 09/2008
2
Docetaxel (Taxotere)
FDA Link
06/2011 - 11/2010
2
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
09/2008 - 07/2007
1
atezolizumab
IBA
11/2023
1
Bevacizumab (Avastin)
FDA Link
11/2023
1
Permethrin (Ambush)
FDA Link
Generic
06/2023
1
Peptides (Polypeptides)
IBA
06/2023
1
Adenosine (Adenocard)
FDA Link
Generic
03/2021
1
Programmed Cell Death 1 Receptor
IBA
03/2021
1
Member 14 Tumor Necrosis Factor Receptors
IBA
03/2021
1
Viral RNA
IBA
01/2021
1
7- methyl- 5- (1- ((3- (trifluoromethyl)phenyl)acetyl)- 2,3- dihydro- 1H- indol- 5- yl)- 7H- pyrrolo(2,3- d)pyrimidin- 4- amine
IBA
03/2020
1
Phosphotransferases (Kinase)
IBA
03/2020
1
Protein Kinases (Protein Kinase)
IBA
03/2020
1
epidermal growth factor receptor VIII
IBA
01/2020
1
Calreticulin
IBA
06/2018
1
Interleukin-6 (Interleukin 6)
IBA
11/2017
1
dipinacoline glutamate
IBA
06/2017
1
Glycogen Synthase (Synthase I)
IBA
06/2017
1
Cytochromes c (Cytochrome c)
IBA
04/2016
1
Monophenol Monooxygenase (Tyrosinase)
IBA
04/2016
1
Sickle Hemoglobin
IBA
01/2016
1
Heme (Haem)
IBA
01/2016
1
Oxidants (Oxidizing Agents)
IBA
01/2016
1
hemoglobin AA
IBA
01/2016
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
05/2015
1
Immunomodulating Agents
IBA
05/2015
1
Enzymes
IBA
02/2015
1
Ganciclovir (Cytovene)
FDA Link
Generic
02/2015
1
Prodrugs
IBA
02/2015
1
Thymidine Kinase
IBA
02/2015
1
Monoclonal Antibodies
IBA
12/2014
1
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
IBA
10/2014
1
Doxorubicin (Adriamycin)
FDA Link
Generic
08/2013
1
trioctyl phosphine oxide (TOPO)
IBA
08/2013
1
Caspase 3 (Caspase-3)
IBA
10/2012
1
Tubulin
IBA
10/2012
1
Interleukin-17 (Interleukin 17)
IBA
03/2012
1
Paclitaxel (Taxol)
FDA Link
Generic
10/2011
1
Small Interfering RNA (siRNA)
IBA
02/2011
Therapy/Procedure
29
Therapeutics
11/2023 - 10/2002
18
Immunotherapy
11/2023 - 06/2002
11
Oncolytic Virotherapy
11/2023 - 12/2002
7
Drug Therapy (Chemotherapy)
01/2021 - 11/2010
1
Intravesical Administration
10/2019
1
Biological Therapy
06/2018
1
Intravenous Administration
11/2015
1
Radiotherapy
11/2015
1
Aftercare (After-Treatment)
05/2015
1
Free Tissue Flaps
02/2015
1
Intravenous Injections
03/2012